ӳ��ý

Publications

Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer.

Tarantino P, Ajari O, Graham N, et al. Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer. European journal of cancer (Oxford, England : 1990). 2024;201:113920. doi:10.1016/j.ejca.2024.113920

Quantitative multiplexed analysis of IDO and ARG1 expression and myeloid cell infiltration in colorectal cancer.

Elomaa H, Härkönen J, Väyrynen SA, et al. Quantitative multiplexed analysis of IDO and ARG1 expression and myeloid cell infiltration in colorectal cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2024:100450. doi:10.1016/j.modpat.2024.100450

A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy.

Voinescu CD, Mozere M, Genovese G, et al. A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy. Kidney international. 2024. doi:10.1016/j.kint.2024.01.017

The UBE2J2/UBE2K-MARCH5 ubiquitination machinery regulates apoptosis in response to venetoclax in acute myeloid leukemia.

Lin S, Schneider C, Su AH, Alexe G, Root DE, Stegmaier K. The UBE2J2/UBE2K-MARCH5 ubiquitination machinery regulates apoptosis in response to venetoclax in acute myeloid leukemia. Leukemia. 2024. doi:10.1038/s41375-024-02178-x

Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: Four prospective US cohort studies.

Tessier AJ, Wang F, Liang L, et al. Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: Four prospective US cohort studies. Med (New York, N.Y.). 2024. doi:10.1016/j.medj.2024.01.010

PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.

Denize T, Jegede OA, Matar S, et al. PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024;30(4):803-813. doi:10.1158/1078-0432.CCR-23-2274

AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.

Monjé N, Dragomir MP, Sinn B V, et al. AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication. British journal of cancer. 2024. doi:10.1038/s41416-023-02550-1

Machine learning for functional protein design.

Notin P, Rollins N, Gal Y, Sander C, Marks D. Machine learning for functional protein design. Nature biotechnology. 2024;42(2):216-228. doi:10.1038/s41587-024-02127-0

Single-cell omics analysis with genome-scale metabolic modeling.

Chen Y, Gustafsson J, Yang J, Nielsen J, Kerkhoven EJ. Single-cell omics analysis with genome-scale metabolic modeling. Current opinion in biotechnology. 2024;86:103078. doi:10.1016/j.copbio.2024.103078

Pan-cancer proteogenomics characterization of tumor immunity.

Petralia F, Ma W, Yaron TM, et al. Pan-cancer proteogenomics characterization of tumor immunity. Cell. 2024. doi:10.1016/j.cell.2024.01.027